Abstract
The most important factor in evaluating patients with chronic cough is the clinicians assessment. This can either suggest the diagnosis or direct investigations as needed. All patients with chronic cough should have a chest radiograph as well as a spirometric examination. The common causes of cough not associated with obvious respiratory disease include asthma and related syndromes, gastro-oesophageal reflux and Post Nasal Drip syndrome. Specialised investigations which may help to establish the diagnosis include broncho-provocation testing, induced sputum cytology, oesophageal manometry, 24-hour oesophageal pH monitoring, computed tomography (CT) and fiberoptic bronchoscopy. Systematic protocols with high diagnostic yields have been described to assess chronic cough. However if there is no ready access to investigations, therapeutic trials targeting the likely cause of cough are justified.
Current Respiratory Medicine Reviews
Title: The Clinical Evaluation of Chronic Cough
Volume: 7 Issue: 1
Author(s): Shoaib Faruqi and Jack A. Kastelik
Affiliation:
Abstract: The most important factor in evaluating patients with chronic cough is the clinicians assessment. This can either suggest the diagnosis or direct investigations as needed. All patients with chronic cough should have a chest radiograph as well as a spirometric examination. The common causes of cough not associated with obvious respiratory disease include asthma and related syndromes, gastro-oesophageal reflux and Post Nasal Drip syndrome. Specialised investigations which may help to establish the diagnosis include broncho-provocation testing, induced sputum cytology, oesophageal manometry, 24-hour oesophageal pH monitoring, computed tomography (CT) and fiberoptic bronchoscopy. Systematic protocols with high diagnostic yields have been described to assess chronic cough. However if there is no ready access to investigations, therapeutic trials targeting the likely cause of cough are justified.
Export Options
About this article
Cite this article as:
Faruqi Shoaib and A. Kastelik Jack, The Clinical Evaluation of Chronic Cough, Current Respiratory Medicine Reviews 2011; 7 (1) . https://dx.doi.org/10.2174/157339811794109336
DOI https://dx.doi.org/10.2174/157339811794109336 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [ Advances in Heme Oxygenase Research as a Potential Therapeutic Strategy Executive Editor: M.J. Alcaraz]
Current Pharmaceutical Design The role of vitamin D towards immune tolerance in white adipose tissue (WAT)
Endocrine, Metabolic & Immune Disorders - Drug Targets Airway Smooth Muscle Phenotype and Function: Interactions with Current Asthma Therapies
Current Drug Targets Abundance and Diversity of GI Microbiota Rather than IgG<sub>4</sub> Levels Correlate with Abdominal Inconvenience and Gut Permeability in Consumers Claiming Food Intolerances
Endocrine, Metabolic & Immune Disorders - Drug Targets Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists
Current Topics in Medicinal Chemistry Anti-Diabetic Drugs GLP-1 Agonists and DPP-4 Inhibitors may Represent Potential Therapeutic Approaches for COVID-19
Endocrine, Metabolic & Immune Disorders - Drug Targets Atypical Chemokine Receptors in Inflammatory Disease
Current Molecular Medicine Risk Factors for Hyperemesis Gravidarum
Current Women`s Health Reviews Dysfunction of Pulmonary Vascular Endothelium in Chronic Obstructive Pulmonary Disease: Basic Considerations for Future Drug Development
Current Drug Metabolism Modeling Anti-Allergic Natural Compounds by Molecular Topology
Combinatorial Chemistry & High Throughput Screening Histamine H3 Receptor (H3R) Antagonists and Inverse Agonists in the Treatment of Sleep Disorders
Current Pharmaceutical Design Advances in Fish Cytokine Biology Give Clues to the Evolution of a Complex Network
Current Pharmaceutical Design 4'-Thionucleosides as Potent and Selective A<sub>3</sub> Adenosine Receptor Ligands
Current Organic Chemistry Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides
Current Pharmaceutical Biotechnology Mast Cells as Targets of Pimecrolimus
Current Pharmaceutical Design Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Novel Therapies for Asthma - Advances and Problems
Current Pharmaceutical Design Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation
Current Medicinal Chemistry Expressed Protein Ligation: A New Tool for the Biosynthesis of Cyclic Polypeptides
Protein & Peptide Letters Development and Validation of a Stability Indicating RP-UPLC Method for Simultaneous Determination of Rupatadine and Montelukast in Pharmaceutical Formulation
Current Pharmaceutical Analysis